Anixa Biosciences Inc
ANIX
Market Cap$104.04M
Close$
$0.03
99% downside
Current Fair Value
99% downsideOvervalued by 99% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $104.04 Million |
|---|---|
| Enterprise Value | $102.35 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.39 |
| Beta | 0.33 |
| Outstanding Shares | 32,202,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.57 |
|---|---|
| PEG | 77.1 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.79 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Anixa Biosciences Inc
CEO: Amit Kumar